about
Simian virus 40 in humansComparing phylogenetic codivergence between polyomaviruses and their hostsInvestigating the origin of AIDS: some ethical dimensionsMesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40Role of the C-terminal region of vervet monkey polyomavirus 1 VP1 in virion formationAbsence of simian virus 40 in human brain tumors from northern India.Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissueGene therapy using SV40-derived vectors: what does the future hold?Does SV40 infection contribute to the development of human cancers?Infectious disease issues in xenotransplantation.Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period.Clues to the etiology of childhood brain cancer: N-nitroso compounds, polyomaviruses, and other factors of interest.Neutralizing and IgG antibodies against simian virus 40 in healthy pregnant women in ItalyLow incidence of SV40-like sequences in ependymal tumours.Molecular identification of simian virus 40 infection in healthy Italian subjects by birth cohort.Influence of the viral regulatory region on tumor induction by simian virus 40 in hamstersPathogenesis and management of polyomavirus infection in transplant recipients.Fanconi anemia patients are more susceptible to infection with tumor virus SV40Serodiagnosis for tumor viruses.Simian virus 40 and human pleural mesothelioma.SV40 Tag DNA sequences, present in a small proportion of human hepatocellular carcinomas, are associated with reduced survival.Emergent human pathogen simian virus 40 and its role in cancer.Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association.Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects.Patterns of polyomavirus SV40 infections and associated cancers in humans: a modelVirus contaminations of cell cultures - A biotechnological view.Episomal simian virus 40 genomes in human brain tumors.Presence of allograft-rejection resistance in simian virus 40-transformed hamster cells and its possible role in tumor development.Ethnic differences in polyomavirus simian virus 40 seroprevalence among women in Houston, TexasInduction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen.Nuclear factor of activated T-cells (NFAT) plays a role in SV40 infection.High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients.Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysisAn update on nonmelanoma skin cancer.Review on the relationship between human polyomaviruses-associated tumors and host immune system.Simian virus 40 infection of humans.SV40-immortalized human fibroblasts as a source of SV40 infectious virions.Threat to Humans from Virus Infections of Non-human Primates.An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.
P2860
Q21202825-28D16FBD-BD66-4363-B724-4FF0E7FBD38AQ24546076-64A83152-303D-498E-AB12-D631BA1D9CCFQ24682301-5D8F417B-DF86-45D1-A4E3-5DF1C07E47DDQ28392429-AFD46E37-F524-4C15-A25D-02DA8B352F21Q28657373-57E7011D-46BB-4951-ABE8-EA3872DBD7D0Q33184266-34F26D51-0E4C-4C4D-AA3F-6B55AC0ABF88Q33186315-61DAD935-C333-4858-B487-DC2A61EA2B14Q33391389-5BC4C176-938C-4135-9219-D955673FB46BQ33755140-F4118BE2-A3C1-4464-AA2A-4900210CF5A4Q33827574-35BB1304-CB66-4BAB-AA7B-0541A9A7887AQ33975598-1ED0317A-FED6-4A74-8E3D-0A9943B35BE6Q34103010-08D8133B-5172-4AB6-9E35-1CAC4AC1A456Q34326832-0E0B4768-EAD8-487F-8E17-2AB74009D492Q34380301-02415742-A128-4E4D-8727-906989569F67Q34464345-640A014F-475A-4A35-AECD-9615D4F701A8Q34572298-A6E2BFDC-49C1-496C-93E4-79F396EF0533Q34708628-D688067D-A52C-4FBA-9322-58D22DA52EE4Q34972029-1CD9C0FA-028B-414C-88AF-7660AA6F4384Q35048631-F0B18C18-4D15-4198-B861-3E5BEBA60724Q35289576-4A440496-5178-41E2-B940-94FDF97A4EAFQ35532774-36E7A8F5-2246-42FE-8F09-580B34737345Q35587200-1BB9C37E-C1F4-4CF3-9074-5D97AC5BA3EFQ35838585-D5DF214A-993F-4768-9630-467F58778384Q35868060-4F85DF31-7065-4CB2-8A42-C26A679AF38EQ35885632-737F6389-183E-44C1-85E3-0EC5C48DEF56Q36173844-3089DDE8-7113-4968-AA8E-28CA1F648C35Q36296676-591B1312-7953-43D8-8A30-118E6447582EQ36375921-819593B4-A5F7-4778-9045-9407BFA02768Q36390070-E36E98DF-D524-4C7A-948A-19743B6C5B71Q36456766-C78B49BC-554E-430F-B2D8-AD976D112AB0Q36473836-F5E3A779-EE34-4B40-9CBA-14AD31ABEA7CQ36532824-26E0100F-06C5-4D7A-9F1E-C799BD1CDD61Q36641726-758ADAD5-7E35-4B69-A36D-8EF677C3F79FQ37458983-357FE49C-5403-40C8-85AA-2AEF4A81B3F7Q37851020-7C0CF59D-DA57-4CC1-A069-85DF1E951FC1Q38001435-B2B4F832-196E-4ABA-B5EF-0B655FEC5FD8Q39748728-4BB56F1E-DF5F-4612-94CA-26ECA53284D6Q40460270-BB7AD629-2057-4819-ADCC-A22DDC63036EQ40636526-E629FE2E-BE40-4348-A5E9-0B9C63F1A823Q40752769-B33ECACB-E237-4D39-A10C-A4CA6C680039
P2860
description
1976 nî lūn-bûn
@nan
1976 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Human exposure to SV40: review and comment.
@ast
Human exposure to SV40: review and comment.
@en
Human exposure to SV40: review and comment.
@nl
type
label
Human exposure to SV40: review and comment.
@ast
Human exposure to SV40: review and comment.
@en
Human exposure to SV40: review and comment.
@nl
prefLabel
Human exposure to SV40: review and comment.
@ast
Human exposure to SV40: review and comment.
@en
Human exposure to SV40: review and comment.
@nl
P1476
Human exposure to SV40: review and comment.
@en
P2093
P356
10.1093/OXFORDJOURNALS.AJE.A112197
P407
P577
1976-01-01T00:00:00Z